Mark W. Bundesmann

机构：Pfizer (United States) · ORCID：0000-0003-1705-3793

发表论文 26 篇 · 总被引 1014 次 · h-index 14

代表论文

• Decarboxylative cross-nucleophile coupling via ligand-to-metal charge transfer photoexcitation of Cu(ii) carboxylates (2022 · Nature Chemistry · 被引 229)
• Visible‐Light‐Initiated Manganese Catalysis for C−H Alkylation of Heteroarenes: Applications and Mechanistic Studies (2017 · Angewandte Chemie International Edition · 被引 187)
• Iron-mediated modular decarboxylative cross-nucleophile coupling (2023 · Chem · 被引 93)
• Total Synthesis of (±)-Cytisine (2000 · Organic Letters · 被引 91)
• Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug–Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors (2015 · Journal of Medicinal Chemistry · 被引 78)
• Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors (2012 · Journal of Medicinal Chemistry · 被引 56)